Inflammatory Mediated Immune Diseases
Inflammatory mediated immune diseases are conditions where the immune system mistakenly attacks the body's own tissues, leading to chronic inflammation and symptoms that can affect various organs and systems.
CIT-013 for Inflammatory Mediated Immune Diseases
We are studying how a new treatment, CIT-013, spreads in the body of patients with inflammatory mediated immune diseases. We also want to learn about its safety and how the body handles it.
≤3 months≤5 visitsEfficacy phase (II)No PlaceboInvestigational MedicinesInjectionInfectious DiseasesRheumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 60 and 85 years old?
- Do you have rheumatoid arthritis (RA) diagnosed for at least 6 months?
- Are you currently pregnant or breastfeeding?
- Do you have a history of severe allergies or multiple drug allergies?
- Do you have an active infection with hepatitis B, hepatitis C, or HIV?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zr-Dfo-Cit-013
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Radboud universitair medisch centrum Stichting
Reumatologie
Nijmegen, Netherlands
Sponsor: Citryll B.V.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.